annual FCF:
-$230.11M-$84.74M(-58.29%)Summary
- As of today (September 16, 2025), AKRO annual free cash flow is -$230.11 million, with the most recent change of -$84.74 million (-58.29%) on December 31, 2024.
- During the last 3 years, AKRO annual FCF has fallen by -$150.43 million (-188.79%).
- AKRO annual FCF is now -5151.19% below its all-time high of -$4.38 million, reached on December 31, 2017.
Performance
AKRO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$48.25M+$19.42M(+28.70%)Summary
- As of today (September 16, 2025), AKRO quarterly free cash flow is -$48.25 million, with the most recent change of +$19.42 million (+28.70%) on June 30, 2025.
- Over the past year, AKRO quarterly FCF has increased by +$9.21 million (+16.03%).
- AKRO quarterly FCF is now -14173.96% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$253.42M+$9.21M(+3.51%)Summary
- As of today (September 16, 2025), AKRO TTM free cash flow is -$253.42 million, with the most recent change of +$9.21 million (+3.51%) on June 30, 2025.
- Over the past year, AKRO TTM FCF has dropped by -$62.48 million (-32.73%).
- AKRO TTM FCF is now -74877.51% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AKRO Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.3% | +16.0% | -32.7% |
| 3 y3 years | -188.8% | -147.3% | -202.8% |
| 5 y5 years | -545.9% | -113.6% | -331.3% |
AKRO Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -188.8% | at low | -147.3% | +31.5% | -202.8% | +3.5% |
| 5 y | 5-year | -545.9% | at low | -253.4% | +31.5% | -331.3% | +3.5% |
| alltime | all time | -5151.2% | at low | <-9999.0% | +31.5% | <-9999.0% | +3.5% |
AKRO Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$48.25M(-28.7%) | -$253.42M(-3.5%) |
| Mar 2025 | - | -$67.66M(+0.9%) | -$262.63M(+14.1%) |
| Dec 2024 | -$230.11M(+58.3%) | -$67.09M(-4.7%) | -$230.11M(+8.7%) |
| Sep 2024 | - | -$70.42M(+22.6%) | -$211.64M(+10.8%) |
| Jun 2024 | - | -$57.45M(+63.5%) | -$190.94M(+22.5%) |
| Mar 2024 | - | -$35.14M(-27.7%) | -$155.88M(+7.2%) |
| Dec 2023 | -$145.37M(+57.1%) | -$48.63M(-2.2%) | -$145.37M(+18.9%) |
| Sep 2023 | - | -$49.72M(+122.1%) | -$122.25M(+25.8%) |
| Jun 2023 | - | -$22.39M(-9.1%) | -$97.15M(+3.1%) |
| Mar 2023 | - | -$24.63M(-3.4%) | -$94.27M(+1.9%) |
| Dec 2022 | -$92.52M(+16.1%) | -$25.51M(+3.6%) | -$92.52M(-1.3%) |
| Sep 2022 | - | -$24.62M(+26.2%) | -$93.70M(+12.0%) |
| Jun 2022 | - | -$19.51M(-14.7%) | -$83.69M(-0.6%) |
| Mar 2022 | - | -$22.88M(-14.3%) | -$84.21M(+5.7%) |
| Dec 2021 | -$79.68M | -$26.70M(+82.8%) | -$79.68M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$14.61M(-27.1%) | -$76.39M(+1.3%) |
| Jun 2021 | - | -$20.03M(+9.2%) | -$75.43M(-3.3%) |
| Mar 2021 | - | -$18.35M(-21.6%) | -$77.98M(+9.9%) |
| Dec 2020 | -$70.95M(+99.2%) | -$23.40M(+71.4%) | -$70.95M(+19.8%) |
| Sep 2020 | - | -$13.65M(-39.6%) | -$59.20M(+0.7%) |
| Jun 2020 | - | -$22.58M(+99.6%) | -$58.76M(+41.6%) |
| Mar 2020 | - | -$11.32M(-2.9%) | -$41.50M(+16.5%) |
| Dec 2019 | -$35.63M(+270.2%) | -$11.65M(-11.8%) | -$35.63M(+36.7%) |
| Sep 2019 | - | -$13.21M(+148.3%) | -$26.05M(+76.0%) |
| Jun 2019 | - | -$5.32M(-2.2%) | -$14.80M(+0.5%) |
| Mar 2019 | - | -$5.44M(+162.4%) | -$14.73M(+53.0%) |
| Dec 2018 | -$9.63M(+119.6%) | -$2.08M(+5.8%) | -$9.63M(+27.5%) |
| Sep 2018 | - | -$1.96M(-62.7%) | -$7.55M(+35.1%) |
| Jun 2018 | - | -$5.25M(+1453.6%) | -$5.59M(+1553.6%) |
| Mar 2018 | - | -$338.00K | -$338.00K |
| Dec 2017 | -$4.38M | - | - |
FAQ
- What is Akero Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual FCF year-on-year change?
- What is Akero Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Akero Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM FCF year-on-year change?
What is Akero Therapeutics, Inc. annual free cash flow?
The current annual FCF of AKRO is -$230.11M
What is the all time high annual FCF for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual free cash flow is -$4.38M
What is Akero Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, AKRO annual free cash flow has changed by -$84.74M (-58.29%)
What is Akero Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of AKRO is -$48.25M
What is the all time high quarterly FCF for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly free cash flow is -$338.00K
What is Akero Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, AKRO quarterly free cash flow has changed by +$9.21M (+16.03%)
What is Akero Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of AKRO is -$253.42M
What is the all time high TTM FCF for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM free cash flow is -$338.00K
What is Akero Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, AKRO TTM free cash flow has changed by -$62.48M (-32.73%)